Rang	Name	Position
1	Mr. Bernard J. Zovighian	CEO & Director
2	Mr. Donald E. Bobo Jr.	Corporate Vice President of Strategy & Corporate Development
3	Mr. Daveen Chopra	Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies
4	Ms. Annette Maria Bruls	Corporate Vice President of EMEA, Canada, & Latin America
5	Ms. Theodora Mistras	Corporate VP & CFO
6	Mr. Joseph Nuzzolese	Corporate Vice President of Global Operations & Quality
7	Mr. Andrew M. Dahl	Principal Accounting Officer, Senior VP & Corporate Controller
8	Dr. Todd Brinton FACC, M.D.	Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer
9	Mr. Snehashish Sarkar	Senior VP and Chief Information & Digital Officer
10	Mr. Mark D. Peterson	Corporate VP & General Counsel

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	10,20%	5,55 Mrd. USD
2	Vanguard Capital Management, LLC	6,53%	3,55 Mrd. USD
3	Vanguard Portfolio Management, LLC	4,58%	2,49 Mrd. USD
4	State Street Corp	4,57%	2,48 Mrd. USD
5	JPMorgan Chase & Co	3,95%	2,15 Mrd. USD
6	Wellington Management Company LLP	2,92%	1,59 Mrd. USD
7	Geode Capital Management, LLC	2,68%	1,46 Mrd. USD
8	Bank of New York Mellon Corp	2,44%	1,33 Mrd. USD
9	DZ BANK AG Deutsche Zentral-Genossenschaftsbank Frankfurt am Main	2,26%	1,23 Mrd. USD
10	Ninety One UK Limited	2,14%	1,16 Mrd. USD
11	Aristotle Capital Management LLC	1,50%	0,82 Mrd. USD
12	AllianceBernstein L.P.	1,50%	0,82 Mrd. USD
13	FMR Inc	1,46%	0,80 Mrd. USD
14	NORGES BANK	1,45%	0,79 Mrd. USD
15	Brown Advisory Holdings Inc	1,28%	0,70 Mrd. USD
16	Bank of America Corp	1,16%	0,63 Mrd. USD
17	Artisan Partners Limited Partnership	1,15%	0,63 Mrd. USD
18	Morgan Stanley - Brokerage Accounts	1,10%	0,60 Mrd. USD
19	Deutsche Bank AG	0,99%	0,54 Mrd. USD
20	Arrowstreet Capital Limited Partnership	0,99%	0,54 Mrd. USD